Please consider downloading the latest version of Internet Explorer
to experience this site as intended.
Tools Search Main Menu


Department of Medicine Grand Rounds

The Dawn of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease, presented by Akram Audi, MDNephrology Fellow, Department of Medicine, Division of Nephrology, and Rickinder Grewal, MD, Nephrology Fellow, Department of Medicine, Division of Nephrology, Both:  University of Rochester Medical Center.

Educational Objectives:

At the conclusion of this presentation participants should be able to:

1.  Understand the pathophysiology and disease course of autosomal dominant polycystic kidney disease.

2.  Understand the indications for tolvaptan in autosomal dominant polycystic kidney disease as well as potential adverse events.


The University of Rochester School of Medicine and Dentistry designates this live educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.    

Tuesday, February 26, 2019 at 12:00pm to 1:00pm

Class of '62 Auditorium
601 Elmwood Avenue, Rochester, NY 14642

Event Type

Medicine and Healthcare, Continuing Education, Grand Rounds


Faculty, Students, Staff, Health Care Professionals

Department of Medicine
Contact Phone or Email

Continuing Education Credits

1 AMA PRA Category 1 Credit(s)TM.

Google Calendar iCal Outlook

Recent Activity